Press release - Shareholders Foundation, Inc. - Deadline on June 25th coming up in Lawsuit for Investors in Exscientia plc (NASDAQ: EXAI) - published on openPR.com
Marketresearch.biz reports that the Generative AI in Pharma market size is expected to be worth around USD 2258.1 Mn by 2033 from USD 159.9 Mn in 2023, growing at a CAGR of 31.2% during the forecast period from 2024 to 2033.Overview of the Generative AI in Pharma MarketGenerative AI in pharma revolutionizes drug dis.
WASHINGTON, Nov. 06, 2023 (GLOBE NEWSWIRE) As per Vantage Market Research, the Global Artificial Intelligence in the Drug Discovery Market has been steadily growing over the years due to the growing demand for personalized medicine, the requirement for effective drug development procedures, and partnerships between pharmaceutical companies and AI technology providers. By analyzing enormous volumes of biological and chemical data, AI algorithms and data analytic approaches are revolutionizing
/PRNewswire/ In the near future, the high-throughput screening (HTS) industry is poised to undergo significant advancements, revolutionizing the field of.